Skip to main content
logo
Forbes Precision Tools and Machine Parts Limited (BOM:544186)
India flag India · Delayed Price · Currency is INR
194.90
-4.65 (-2.33%)
At close: Aug 1, 2025

Sage Therapeutics Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Mar '25 Mar '24 Mar '23
Revenue
2,3272,285-
Revenue Growth (YoY)
1.82%--
Cost of Revenue
878.2860.27-
Gross Profit
1,4481,425-
Selling, General & Admin
464.93430.47-
Other Operating Expenses
469.04475.870.12
Operating Expenses
1,0691,0250.12
Operating Income
378.99399.97-0.12
Interest Expense
-11.28-11.45-
Interest & Investment Income
1.671.7-
Currency Exchange Gain (Loss)
-2.07-0.68-
Other Non Operating Income (Expenses)
39.818.03-
EBT Excluding Unusual Items
407.13397.57-0.12
Gain (Loss) on Sale of Investments
2.25--
Gain (Loss) on Sale of Assets
-0.620.36-
Other Unusual Items
-0.38-
Pretax Income
408.76398.3-0.12
Income Tax Expense
121.3101.19-
Net Income
287.46297.11-0.12
Net Income to Common
287.46297.11-0.12
Net Income Growth
-3.25%--
Shares Outstanding (Basic)
5230
Shares Outstanding (Diluted)
5230
Shares Change (YoY)
1821.05%5271.48%-
EPS (Basic)
5.57110.63-2.36
EPS (Diluted)
5.57110.63-2.36
EPS Growth
-94.96%--
Free Cash Flow
230.53-878.08-
Free Cash Flow Per Share
4.47-326.94-
Dividend Per Share
5.000--
Gross Margin
62.25%62.35%-
Operating Margin
16.29%17.51%-
Profit Margin
12.35%13.00%-
Free Cash Flow Margin
9.91%-38.43%-
EBITDA
496.94508.49-
EBITDA Margin
21.36%22.25%-
D&A For EBITDA
117.95108.52-
EBIT
378.99399.97-0.12
EBIT Margin
16.29%17.51%-
Effective Tax Rate
29.68%25.41%-
Revenue as Reported
2,3702,296-
Advertising Expenses
23.7219.55-
Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.